Thursday, February 4, 2021 marks World Cancer Day. This date was selected in 2000 by the Union for International Cancer Control (UICC) as a positive way to unite the globe in the fight against cancer. Statistics compiled by the American Cancer Society show that there were 17 million cancer cases diagnosed worldwide and 9.5 million […]
Posts by :
In the latest Kimmel in DC podcast, Dr Ashwani Rajput talks with Dr Michael Pishvaian about treating patients with gastrointestinal cancers, specifically colorectal cancer and pancreatic cancer, as well as the importance of clinical trials in developing improved standard practices of care.
In this Cancer Matters podcast, Dr Bill Nelson speaks with Dr J James Frost about his recent paper, 'Cancer's Intelligence,' on how the disease plots its growth in the body to overcome our efforts to stop it. To read more on Dr Frost's work, click here: https://www.eurekalert.org/pub_releases/2020-12/swbc-ci122220.php
In this Cancer Matters podcast, Dr Bill Nelson talks to Dina Lansey and Dr Otis Brawley about their work using resources from the state of Maryland's Cigarette Restitution Fund to educate patient populations on the benefits of clinical trials and overcome barriers to participation.
V Foundation Recognizes Dr. Vered Stearns’ and Dr. Roisin Connolly’s Work with Grant from Stuart Scott Fund Memorial Cancer Research Fund
The V Foundation awarded Dr Vered Stearns and Dr Roisin Connolly a research grant from the Stuart Scott Memorial Cancer Research Fund for their work on metastatic Triple Negative Breast Cancer in minority patients. “The challenge is that even within a type of cancer there are multiple subtypes, and it is hard for one investigator […]
Liver cancer is one of the fastest-growing causes of cancer death in the U.S. and in many other parts of the world, says Mark Yarchoan, co-director of the Liver Cancer Multidisciplinary Clinic. Since the new liver cancer clinic launched a little more than a year ago, they have seen a more than 500% increase in […]
Arnold’s advanced pancreas cancer that had spread to his liver was eliminated with a low-dose, five-drug combination being studied in a clinical trial led by Dung Le. Le is now testing new iterations of the therapy to see if she can help more patients. A new drug cocktail adds immunotherapy and a PARP inhibitor to […]